Skip to main content
. 2021 Dec 27;14(1):45. doi: 10.3390/pharmaceutics14010045
AMPK adenosine monophosphate-activated protein kinase
DAG diacylglycerol
EET eicosatetraenoic acid
FAS fatty acid synthase
GSH reduced form of glutathione
GSSG oxidised form of glutathione
HETE hydroxytetraenoic acid
HHTg hereditary hypertriglyceridaemia
HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase
HPLC High Performance Liquid Chromatography
4-HNE 4-hydroxynonenale
hsCRP high-sensitivity C-reactive protein
IL-6 interleukin 6
MDA malondialdehyde
MAPK mitogen-activated protein kinase
MCP-1 monocyte chemoattractant protein-1
NAFLD non-alcoholic fatty liver disease
FFA free fatty acid
NF-κB nuclear factor kappa B
NASH non-alcoholic steatohepatitis
NRF2 nuclear factor erythroid-2-related factor 2
PPAR peroxisome proliferator-activated receptor
PUFA polyunsaturated fatty acid
ROS reactive oxygen species
SCD stearoyl-coenzyme A desaturase
SOD superoxide dismutase
SREBP sterol regulatory element-binding protein
TAG triacylglycerol
TNFα tumour necrosis factor alpha
VLDL very-low-density lipoprotein